Non-GAAP Q1 2019 EPS Rose 25% to $1.04
JOHNS CREEK, GA – May 9, 2019 – Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today reported results for its first quarter ended March 31, 2019. Ebix will host a conference call to review its results today at 11:00 a.m. EDT (details below).
Ebix delivered the following results for the first quarter of 2019:
Revenue: Q1 2019 revenue rose 32% to $142.9 million compared to $108.2 million in Q1 2018 and increased 5% over Q4 2018 revenue of $136.3 million. The year over year revenue improvement reflected growth in the Company’s EbixCash channel. On a constant currency basis, Ebix Q1 2019 revenue increased 37% to $148.0 million compared to $108.2 million in Q1 2018. Exchanges cumulatively including the insurance and EbixCash financial exchanges accounted for 88% of Q1 2019 revenues.
| (dollar amounts in thousands) | ||||||
| Channel | Q1 2019 | Q1 2018 | Change | |||
| EbixCash Exchanges | $ 77,737 | $ 36,008 | +116% | |||
| Insurance Exchanges | 48,105 | 49,163 | -2% | |||
| RCS | 17,172 | 23,059 | -26% | |||
| Total Revenue | $142,924 | $ 108,230 | +32% | |||
| Total Revenue on Constant Currency Basis | $ 148.0M | $ 108.2M | +37% | |||
Operating Income and Margins: Q1 2019 GAAP operating margins increased to 38% as compared to 31% in Q1 2018 and GAAP Operating income for Q1 2019 rose 60% to $54.1 million compared to $33.9 million in Q1 2018 due to a $15.4 million reduction of acquisition accrual for ItzCash, offset by $3.4 million of one-time expenses primarily associated with new acquisitions.
Non-GAAP operating margins for Q1 2019 were 30% while non-GAAP operating income was $42.8 million in the quarter.
Operating Cash: Cash generated from operations rose $13.0 million or 51% in Q1 2019 to $38.5 million compared to $25.5 million in Q1 2018. Q1 2019 cash flows were strong in spite of cumulative cash payments of $13.7 million for bank interest and income tax, including non-recurring advance Minimum Alternate Tax (MAT) payments in India.
Net Income and EPS: Q1 2019 GAAP net income decreased 2% to $25.7 million compared to $26.2 million in Q1 2018, principally due to a $20.5 million Derivative Case Legal Settlement and other related legal fees, reported in non-operating expenses. Q1 2019 GAAP diluted earnings per share rose 1% to $0.84 from Q1 2018 of $0.83.
Non-GAAP net income increased 21% to $31.8 million after excluding certain items including the one-time earn-out reversal of $15.4 million, one-time legal expenses of $20.4 million and one-time acquisition related expenses of $3.4 million. The non-GAAP diluted earnings per share in Q1 2019 grew 25% to $1.04 as compared to Q1 2018. Ebix’s weighted average diluted shares outstanding decreased to 30.6 million in Q1 2019 compared to 31.7 million in Q1 2018 and 31.2 million in Q4 2018, reflecting the benefit of share repurchase activity.
Share Repurchases: In Q1 2019, Ebix repurchased 250,000 shares of its outstanding common stock for aggregate cash consideration of $11.0 million. Included in these figures was the repurchase of 200,000 shares in December for a total of $8.8 million that were not settled until January 2019.
Q2 2019 Diluted Share Count: As of today, Ebix expects its diluted share count for Q2 2019 to be approximately 30.7 million.
Dividend: Ebix paid its regular quarterly dividend of $0.075 per share in Q1 2019 for a total cost of $2.3 million.
Ebix Chairman, President and CEO Robin Raina said, “With constant currency revenues of $148 million in the quarter, we are now getting close to an annual run rate of $600 million in revenues. In Q1 2019, we reported sequential revenue growth of 5% and year-over-year growth of 32%. We are pleased that we have done that in spite of year-over-year currency head winds of $5.1 million; our conscious decision of reducing revenues from our comparatively lower margin e-governance business in India from an average quarterly run rate of approximately $6.5 million to less than $100,000 in Q1 2019; and the traditional seasonal reductions in revenues of $4 million in the Health and CME areas, as compared to Q4 2018. We are especially pleased that we have shown this revenue growth while keeping our operating margins intact.”
Robin said, “We are excited to be reporting the highest operating cash flow quarter ever, of $38.5 million in Q1 2019. To be able to do that, while investing in growing our businesses and for example funding our business to handle $15 billion in gross merchandise value in India alone, is especially pleasing to us. In our viewpoint, it speaks to the fundamental strength of our businesses.
We are excited with the sales pipeline we are building in all our businesses - both in the area of insurance and financial exchanges. In recent times, we have won a number of key deals in the insurance and finance sectors internationally, that can move the needle substantially for us in terms of revenues. We remain focused on getting beyond $800 million in Quarterly Annualized revenues, by Q4 of 2019.”
Sean Donaghy, Ebix CFO said, “Ebix’s $38.5 million of Q1 2019 operating cash flow is a 145% improvement sequentially over Q4 2018, and a 51% improvement over Q1 2018. The Company continues to grow efficiently, consistently producing operating margins of 30% while continuing to show substantial year-over-year revenue growth. During Q1 2019, we spent $10.2 million on dividends, tax payments and principal Bank payments. Specifically, in Q1 2019 we paid taxes and principal bank payments of $7.9 million, invested $90.4 million on acquisitions, paid $4.9 million to reacquire the balance 10% stake in the MTSS business, repurchased Ebix stock worth $11 million, and returned $2.3 million in dividends to shareholders, while we drew only $13.5 million from our Bank credit facilities. In spite of that, Ebix ended the quarter with $96.4 million of cash, cash equivalents, and short-term investments.”
Reconciliation of GAAP net income and diluted earnings per share to non-GAAP net income and diluted earnings per share. Non-GAAP information is provided to enhance the understanding of the Company's financial performance and is reconciled to the Company's GAAP information in the accompanying tables.
| Net Income | Diluted EPS | |
| First Quarter 2019 GAAP Results | $25,710 | $0.84 |
| Non-GAAP Adjustments: | ||
| Legal settlement and associated fees | 20,452 | $0.67 |
| One-time quarterly expenses | 3,435 | $0.11 |
| Stock based compensation | 576 | $0.02 |
| Reduction of acquisition earn-out accrual | (15,392) | $(0.50) |
| One-time net tax benefit | (3,000) | $(0.10) |
| Total Non-GAAP Adjustments | 6,071 | $0.20 |
| First Quarter 2019 Non-GAAP Results | $31,781 | $1.04 |
| Call Date/Time: | Thursday, May 9, 2019 at 11:00 a.m. EST |
| Call Dial-In: | +1-877-837-3909 or 1-973-409-9690; Call ID # 13609854 |
| Live Audio Webcast: | www.ebix.com/webcast |
| Audio Replay URL: | www.ebix.com/result_19_Q1 after 2:00 p.m. EDT on May 9th |
About Ebix, Inc.
With 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing Software-as-a-Service ("SaaS") enterprise solutions in the area of CRM, front-end & back-end systems, outsourced administration and risk compliance services, around the world.
With a "Phygital” strategy that combines 320,000 physical distribution outlets in many Southeast Asian Nations (“ASEAN”) countries, to an Omni-channel online digital platform, the Company’s EbixCash Financial exchange portfolio encompasses leadership in areas of domestic & international money remittance, foreign exchange (Forex), travel, pre-paid & gift cards, utility payments, lending, wealth management etc. in India and other markets. EbixCash’s Forex operations have emerged as a leader in India’s airport Foreign Exchange business with operations in 32 international airports including Delhi, Mumbai, Bangalore, Hyderabad, Chennai and Kolkata, conducting over $4.8 billion in gross transaction value per year. EbixCash’s inward remittance business in India conducts approx. $5 billion gross annual remittance business, confirming its undisputed leadership position in India. EbixCash, through its travel portfolio of Via and Mercury, is also one of Southeast Asia’s leading travel exchanges with over 2,200+ employees, 212,450+ agent network, 25 branches and over 9,800 corporate clients; processing an estimated $2.5 billion in gross merchandise value per year. EbixCash’s technology services Division has emerged as a leader in the areas of lending technology, asset & wealth management technology, travel technology in India; besides having grown its international expanse to Europe, Middle East, Africa and ASEAN countries.
Through its various SaaS-based software platforms, Ebix employs thousands of domain-specific technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company’s website at www.ebix.com
SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS
As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.
The information contained in this Press Release contains forward-looking statements and information within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company's products by the market, and management's plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission ("SEC"), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "seeks," "plan," "project," "continue," "predict," "will," "should," and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.
Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company's ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia, UK and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.
Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.
Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.
You may obtain our SEC filings at our website, www.ebix.com under the "Investor Information" section, or over the Internet at the SEC's web site, www.sec.gov.
| Darren Joseph 678-281-2027 or IR@ebix.com |
David Collins or Chris Eddy Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com |
Ebix, Inc. and Subsidiaries
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | ||
| March 31, | ||
| 2019 | 2018 | |
| Operating revenue | $ 142,924 | $ 108,230 |
| Operating expenses: | ||
| Cost of services provided | 45,929 | 39,591 |
| Product development | 11,242 | 8,434 |
| Sales and marketing | 6,121 | 3,998 |
| General and administrative, net | 21,444 | 19,504 |
| Amortization and depreciation | 4,057 | 2,807 |
| Total operating expenses | 88,793 | 74,334 |
| Operating income | 54,131 | 33,896 |
| Interest income | 350 | 121 |
| Interest expense | (9,818) | (4,847) |
| Non-operating income | 3 | 53 |
| Non-operating expense - litigation settlement | (20,452) | - |
| Foreign currency exchange loss | (255) | (641) |
| Income before income taxes | 23,959 | 28,582 |
| Income tax benefit (expense) | 1,084 | (2,126) |
| Net income including noncontrolling interest | 25,043 | 26,456 |
| Net income (loss) attributable to noncontrolling interest | (667) | 248 |
| Net income attributable to Ebix, Inc. | $ 25,710 | $ 26,208 |
| Basic earnings per common share attributable to Ebix, Inc. | $ 0.84 | $ 0.83 |
| Diluted earnings per common share attributable to Ebix, Inc. | $ 0.84 | $ 0.83 |
| Basic weighted average shares outstanding | 30,524 | 31,482 |
| Diluted weighted average shares outstanding | 30,604 | 31,659 |
Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
| March 31, 2019 |
December 31, 2018 |
|
| ASSETS | (Unaudited) | |
| Current assets: | ||
| Cash and cash equivalents | $ 76,999 | $ 147,766 |
| Short-term investments | 19,417 | 31,192 |
| Restricted cash | 29,743 | 8,317 |
| Fiduciary funds- restricted | 3,395 | 6,491 |
| Trade accounts receivable, less allowances of $6,619 and $6,969, respectively | 162,155 | 174,340 |
| Other current assets | 60,838 | 59,274 |
| Total current assets | 352,547 | 427,380 |
| Property and equipment, net | 50,012 | 50,294 |
| Right-of-use assets | 19,005 | - |
| Goodwill | 965,640 | 946,685 |
| Intangibles, net | 48,559 | 51,448 |
| Indefinite-lived intangibles | 42,055 | 42,055 |
| Capitalized software development costs, net | 12,905 | 11,742 |
| Deferred tax asset, net | 58,686 | 54,629 |
| Other assets | 31,583 | 26,714 |
| Total assets | $ 1,580,992 | $ 1,610,947 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $ 121,180 | $130,221 |
| Accrued payroll and related benefits | 8,334 | 9,227 |
| Cash overdraft | 18,925 | 17,841 |
| Fiduciary funds- restricted | 3,395 | 6,491 |
| Short-term debt | 1,441 | 3,990 |
| Current portion of long-term debt and financing lease obligation, net of deferred financing costs of $575 |
16,368 | 14,603 |
| Lease liability | 6,046 | - |
| Contingent liability for accrued earn-out acquisition consideration | 2,291 | 13,767 |
| Accrued litigation settlement | 19,652 | - |
| Deferred revenue | 33,173 | 35,609 |
| Other current liabilities | 11,349 | 85,679 |
| Total current liabilities | 242,154 | 317,428 |
| Revolving line of credit | 438,037 | 424,537 |
| Long term debt and capital lease obligations, less current portion, net of deferred financing costs of $1,666 and $1,811, respectively | 271,075 | 274,716 |
| Other liabilities | 27,848 | 28,287 |
| Contingent liability for accrued earn-out acquisition consideration | 10,175 | 11,209 |
| Deferred revenue | 8,649 | 9,051 |
| Deferred tax liability, net | 1,282 | 1,282 |
| Lease liability | 12,724 | - |
| Total liabilities | 1,011,944 | 1,066,510 |
| Commitments and Contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2019 and December 31, 2018 | - | - |
| Common stock, $0.10 par value, 220,000,000 shares authorized, 30,523,756 issued and outstanding, at March 31, 2019, and 30,567,725 issued and outstanding at December 31, 2018 | 3,052 | 3,057 |
| Additional paid-in capital | 4,350 | 3,397 |
| Retained earnings | 556,364 | 535,118 |
| Accumulated other comprehensive loss | (59,895) | (63,377) |
| Total Ebix, Inc. stockholders’ equity | 503,871 | 478,195 |
| Noncontrolling interest | 65,177 | 66,242 |
| Total stockholders’ equity | 569,048 | 544,437 |
| Total liabilities and stockholders’ equity | $ 1,580,992 | $ 1,610,947 |
Ebix, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited)
| Three Months Ended | ||
| March 31, | ||
| 2019 | 2018 | |
| Cash flows from operating activities: | ||
| Net income attributable to Ebix, Inc. | $ 25,710 | $ 26,208 |
| Net income (loss) attributable to noncontrolling interest | (667) | 248 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Amortization and depreciation | 4,057 | 2,807 |
| Benefit for deferred taxes | (3,875) | (1,874) |
| Share based compensation | 576 | 753 |
| Provision for doubtful accounts | 134 | 1,045 |
| Amortization of right-of-use assets | 1,671 | - |
| Unrealized foreign exchange loss | 313 | 419 |
| Amortization of capitalized software development costs | 596 | 525 |
| Reduction of acquisition accruals | (15,392) | - |
| Changes in assets and liabilities, net of effects from acquisitions: | ||
| Accounts receivable | 8,751 | (1,401) |
| Other assets | 3,142 | (554 |
| Accounts payable and accrued expenses | (2,156) | 1,438 |
| Accrued payroll and related benefits | (1,208) | (946) |
| Deferred revenue | (2,920) | (2,361) |
| Lease liabilities | (1,643) | (317) |
| Reserve for potential uncertain income tax return positions | - | 30 |
| Liability - derivative litigation settlement | 19,652 | - |
| Other liabilities | 1,754 | (527) |
| Net cash provided by operating activities | 38,495 | 25,493 |
| Cash flows from investing activities: | ||
| Acquisition of Transcorp | - | (6,554) |
| Cash (paid to) received from Paul Merchants for 10% stake in MTSS combined business | (4,925) | 4,996 |
| Acquisition of Weizmann, net of cash acquired | (64,624) | - |
| Acquisition of Pearl | (3,372) | - |
| Acquisition of Lawson | (2,726) | - |
| Acquisition of Miles | (982) | - |
| Acquisition of Business Travels | (689) | - |
| Cash paid for acquisition of Wahh taxis | (214) | - |
| Cash paid for acquisition of Zillious, net of cash acquired | (9,816) | - |
| Cash paid for acquisition of Essel Forex | (7,935) | - |
| Capitalized software development costs paid | (1,740) | (622) |
| Maturities of marketable securities | 11,775 | 5,198 |
| Capital expenditures | (1,798) | (531) |
| Net cash provided by (used in) investing activities | (87,046) | 2,487 |
| Cash flows from financing activities: | ||
| (Repayments of) proceeds from revolving line of credit, net | 13,500 | (100,835) |
| Proceeds from term loan | - | 124,250 |
| Principal payments of term loan obligation | (3,766) | - |
| Repurchases of common stock | (10,972) | - |
| Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested | (21) | (36) |
| Dividend payments | (2,297) | (2,369) |
| Other | 2,908 | - |
| Principal payments of debt obligations | (834) | - |
| Cash overdraft | 1,070 | 745 |
| Payments of capital lease obligations | (69) | - |
| Net cash provided by (used in) financing activities | (481) | 21,755 |
| Effect of foreign exchange rates on cash | 190 | (1,723) |
| Net change in cash and cash equivalents, and restricted cash | (48,842) | 48,012 |
| Cash and cash equivalents, and restricted cash at the beginning of the period | 159,589 | 70,867 |
| Cash and cash equivalents, and restricted cash at the end of the period | $ 110,747 | $ 118,879 |
| Supplemental disclosures of cash flow information: | ||
| Interest paid | $ 9,573 | $ 4,280 |
| Income taxes paid | $ 4,128 | $ 6,751 |